Evidence map›Paper›PMID 39066175›Full record

ArticleViruses2024

Immunogenetic Profile Associated with Patients Living with HIV-1 and Epstein-Barr Virus (EBV) in the Brazilian Amazon Region.

Iran Barros Costa, Mayara Natália Santana-da-Silva, Patrícia Yuri Nogami, Carolinne de Jesus Santos E Santos, Leonn Mendes Soares Pereira, Eliane Dos Santos França, Amaury Bentes Cunha Freire, Francisco Lúzio de Paula Ramos, Talita Antonia Furtado Monteiro, Olinda Macedo and 4 more

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Iran Barros CostaEpstein-Barr Virus Laboratory, Virology Department, Evandro Chagas Institute, Ananindeua 67030-000, PA, Brazil.
Mayara Natália Santana-da-SilvaEpstein-Barr Virus Laboratory, Virology Department, Evandro Chagas Institute, Ananindeua 67030-000, PA, Brazil.
Patrícia Yuri NogamiEpstein-Barr Virus Laboratory, Virology Department, Evandro Chagas Institute, Ananindeua 67030-000, PA, Brazil.
Carolinne de Jesus Santos E SantosEpstein-Barr Virus Laboratory, Virology Department, Evandro Chagas Institute, Ananindeua 67030-000, PA, Brazil.
Leonn Mendes Soares PereiraVirology Laboratory, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.
Eliane Dos Santos FrançaEpstein-Barr Virus Laboratory, Virology Department, Evandro Chagas Institute, Ananindeua 67030-000, PA, Brazil.
Amaury Bentes Cunha FreireEpidemiology and Surveillance Service, Evandro Chagas Institute, Ananindeua 67030-000, PA, Brazil.
Francisco Lúzio de Paula RamosEpidemiology and Surveillance Service, Evandro Chagas Institute, Ananindeua 67030-000, PA, Brazil.
Talita Antonia Furtado MonteiroEpstein-Barr Virus Laboratory, Virology Department, Evandro Chagas Institute, Ananindeua 67030-000, PA, Brazil.
Olinda MacedoRetrovirus Laboratory, Virology Department, Evandro Chagas Institute, Ananindeua 67030-000, PA, Brazil.
Rita Catarina Medeiros SousaSchool of Medicine, Federal University of Pará, Belém 66075-110, PA, Brazil.
Felipe Bonfim FreitasRetrovirus Laboratory, Virology Department, Evandro Chagas Institute, Ananindeua 67030-000, PA, Brazil.ORCID 0000-0002-4325-3695
Antonio Carlos Rosário VallinotoVirology Laboratory, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0003-1135-6507
Igor Brasil-CostaEpstein-Barr Virus Laboratory, Virology Department, Evandro Chagas Institute, Ananindeua 67030-000, PA, Brazil.ORCID 0000-0003-2600-4109

Funding

National Council for Scientific and Technological Development CNPQ-301869/2017-0
6 · The paper itself

Abstract

Viral coinfection among HIV-positive patients, coupled with the development of AIDS, remains a major public health problem. The synergism between the presence of HIV and other viruses has consequences in relation to changes in the severity of the infection, as well as changes in the natural course of both infections. Several polymorphisms present in genes that encode cytokines have a relevant influence on their transcription and consequently on the production of such immunological molecules. The present study evaluated the influence of SNPs located in the promoter regions of genes encoding the cytokines INF-ɣ, TNF, IL-6, IL-4, and IL-2, as well as their respective plasma concentrations, in patients infected with HIV and/or EBV in the state of Pará. Additionally, this study described the epidemiological profile and compared CD4+ and CD8+ T lymphocyte counts among the groups studied. The associative analysis between the SNPs and plasma cytokine concentrations in different groups showed statistical relevance for three polymorphisms: rs2069762 (

Indexed as

CoinfectionCytokinesEpstein-Barr Virus InfectionsHerpesvirus 4, HumanHIV-1HIV InfectionsPolymorphism, Single NucleotideAdultBrazilCD4 Lymphocyte CountCD8-Positive T-LymphocytesFemaleGenotypeHumansImmunogeneticsMaleCytokinescytokinesEBVHIVpolymorphismsingle nucleotide

Identifiers

PMID39066175
PMCPMC11281405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.